Tuesday, August 25, 2009

Epitope-Enhanced TARP Peptide Vaccine Versus TARP Peptide-Pulsed Dendritic Cells

A new NIH Bethesda, MD clinical trial. TARP Peptide trial. This is a good trial protocol as both arms get some presumed effective drug. Trials with placebos dealing with fatal illnesses seem to be ethically challenging.

No comments:

Post a Comment